These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7562470)

  • 1. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
    Cockcroft JR; Chowienczyk PJ; Brett SE; Chen CP; Dupont AG; Van Nueten L; Wooding SJ; Ritter JM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1067-71. PubMed ID: 7562470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebivolol: endothelium-mediated vasodilating effect.
    Ritter JM
    J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
    van Lieburg AF; Knoers NV; Monnens LA; Smits P
    J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo.
    Seddon MD; Chowienczyk PJ; Brett SE; Casadei B; Shah AM
    Circulation; 2008 Apr; 117(15):1991-6. PubMed ID: 18391107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
    J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide mediated venodilator effects of nebivolol.
    Bowman AJ; Chen CP; Ford GA
    Br J Clin Pharmacol; 1994 Sep; 38(3):199-204. PubMed ID: 7826820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
    Prisant LM
    J Clin Pharmacol; 2008 Feb; 48(2):225-39. PubMed ID: 18083889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5 HT1A-receptors.
    Chlopicki S; Kozlovski VI; Gryglewski RJ
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):615-24. PubMed ID: 12512696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.
    Dawes M; Brett SE; Chowienczyk PJ; Mant TG; Ritter JM
    Br J Clin Pharmacol; 1999 Sep; 48(3):460-3. PubMed ID: 10510163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
    Calver A; Collier J; Moncada S; Vallance P
    J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S; Wright HM
    Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring vascular benefits of endothelium-derived nitric oxide.
    Cockcroft JR
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):177S-183S. PubMed ID: 16373196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
    Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
    Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nebivolol on human platelet aggregation.
    Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
    Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
    Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
    Greven J; Gabriëls G
    Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE; Philipp T
    Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
    Schindler C; Leuschner S; Schwanebeck U; Kirch W
    J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature.
    Dawes M; Chowienczyk PJ; Ritter JM
    Br J Pharmacol; 2001 Nov; 134(5):939-44. PubMed ID: 11682440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.